Clinical Trials Browser

OTHER × Anorexia × 1 year × Clear all

NCT04939090 2026-03-04

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Phase 3 Recruiting

Other hematologic neoplasm

Anorexia, Hematologic Neoplasms

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase 2 Recruiting

Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Phase 2 Terminated

4 enrolled 12 charts

Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT00489307 2025-11-12

Dexamethasone for Symptom Burden in Advanced Cancer Patients

Phase 2 Active not recruiting

132 enrolled 15 charts

Anorexia, Fatigue, Nausea, Pain

NCT03637816 2025-11-03

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Phase 2/3 Active not recruiting

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07179094 2025-09-17

The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash

Phase NA Not yet recruiting

Other hematologic neoplasm

Anorexia, Nausea, Vomiting, Hematologic Neoplasms

NCT04906746 2025-07-28

Ruxolitinib for Cancer Cachexia

Phase EARLY_PHASE1 Active not recruiting

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Muscular Atrophy